Newsgroup: it.scienza.biologia
Titolo: cancro e statistiche ufficiali

DOMANDA a TUTTI gli ONCOLOGI del MONDO delle medicina allopatica detta
ufficiale:
 Quali sono gli Studi scientifici e quali sono le statistiche di guarigione
che fanno assurgere il trattamento chemioterapico
 a terapia convenzionale d'eccellenza nel trattamento dei tumori
 e che dovrebbero quindi far prevalere per tale approccio terapeutico ?
vedi: 
http://www.mednat.info/cancro/nacci_chemio_statistiche_uff.htm
-- 
dr. G. Paolo Vanoli -  Giornalista pubblicista, Consulente in Scienza della
Nutrizione e Medicine Biologico Naturali
www.mednat.org/curriculum.htm

 
Domanda a te e al tuo compare Simoncini: da quanti tessuti cancerosi 
avete isolato la Candida?
E i dati a supporto della vostra tesi dove sono reperibili?

 ha scritto nel messaggio 
news:gspis3$vff$1...@newsserver.cilea.it...

Vedo che non sei informato, ne' aggiornato:
http://www.mednat.org/cancro/cancer_candida.htm
http://www.mednat.org/cancro/candida_concausa.htm
ed altre ancora...
-- 
dr. G. Paolo Vanoli - Giornalista pubblicista - Consulente in Scienza della 
Nutrizione e Medicine Naturali
http://www.mednat.org/curriculum.htm
"Prima ti ignorano. Poi ti deridono. Poi ti combattono. E poi tu vinci"
(Gandhi)

 
Hai dei seri problemi cognitivi, ormai è appurato:
"C. Albicans can cause serious and potentially life-threatening 
infections in the mouth, blood and other tissues of people who are 
undergoing cancer chemotherapy or radiation treatments, or who have 
developed AIDS or other diseases that damage the immunity of the 
individual."
"In a surveillance study of candidemia in cancer patients that was 
conducted by the European Organization for Research and Treatment of 
Cancer, 249 episodes were noted;
Candida Albicans was isolated in 70% (63) of the 90 cases involving 
patients with solid tumors (tumor patients) and  in 36% (58) of the 159 
involving those with hematologic disease (hematology patients). 
Neutropenia in tumor patients and acute leukemia and antifungal 
prophylaxis in hematology patients were significantly associated with 
non-Albicans candidemia in a multivariate analysis.
Overall 30-day mortality was 39% (97 of 249). In a univariate analysis, 
Candida glabrata was associated with the highest mortality rate (odds 
ratio, 2.66). Two multivariate analyses showed that mortality was 
associated with older age and severity of the underlying disease. Among 
hematology patients, additional factors associated with mortality were 
allogeneic bone marrow transplantation, septic shock, and lack of 
antifungal prophylaxis."
"Fungal infection represents a growing problem in children with 
hematologic malignancies. During chemotherapy induced neutropenia, 
colonization with fungi is considered a major risk factor for subsequent 
fungal infection. [cut] CONCLUSIONS: Our findings suggest that there is 
a high rate of fungal colonization in children receiving remission 
induction therapy for acute leukemia and lymphoma. Limiting the use of 
antibiotics and instituting antifungal chemoprophylaxis may decrease the 
rate, while the early initiation of empiric antifungal therapy in 
patients with fever and suspected mycotic colonization may increase 
survival in these patients."
"A model of oral mucosal carcinogenesis using the water-soluble 
carcinogen 4-nitroquinoline-1-oxide (4NQO) was combined with a model of 
oral mucosal candidosis to examine the ability of Candida Albicans to 
promote the development of neoplasia in suitably initiated epithelium. 
Sprague-Dawley rats were initiated by the application of 4NQO to their 
palatal and tongue mucosa 3 times weekly for 4 weeks. The animals then 
received either application of a phorbol ester to act as a promoter, 
induction of experimental oral mucosal infection with C. Albicans, or no 
further procedures. Animals were killed at 34 or 52 weeks and the 
tongues and palates sectioned for light-microscopic examination. Control 
groups with no treatment, mucosal infection only, phorbol ester 
application only, 4NQO with the tetracycline or vehicle application only 
were also used.
The development of carcinoma in the experimental groups was similar to 
that in the positive control groups, indicating that the particular 
strain of Candida used had a similar ability to promote neoplastic 
changes as the known promoter phorbol-12,13- didecanoate and caused 
neoplastic changes to occur by week 34 with no additional lesions 
occurring by week 52. This indicated that the speculation that strains 
of C. Albicans may participate in causing neoplastic transformation in 
humans was well founded.
Copyright © 1992 by Oxford University Press."
"Twenty-five patients with carcinoma of the esophagus (group I) and 25 
patients suffering from non-ulcer dyspepsia with normal endoscopy (group 
II) were studied to know the incidence of isolation of Candida from 
their esophagus. Endoscopic brushings were taken from the esophagus in 
both groups and studied by smear examination and culture. Fungal 
organisms could be detected in 75% of cases of group I and 32% of cases 
of group II by culture techniques, and 45.8% and 12% respectively by 
smear examination. The difference was statistically significant (p less 
than 0.05) for both the techniques. Candida Albicans was the commonest 
species isolated. No correlation was found between Candida agglutination 
titres and density of Candida growth on culture. We conclude that an 
association exists between carcinoma esophagus and the occurrence of 
Candida in the esophagus. "
Mi sono fermato qui.
Nessuno dice che Candida albicans abbia responsabilità nell'eziologia di 
malattie. E' un fungo opportunista che aumenta la propria presenza nei 
tessuti di organismi con immunodepressioni.
Altrimenti devi aver paura pure di molti Aspergillus, Fusarium, 
Trichoderma, Penicillium e tanti altri funghi a carattere 
opportunistico, capaci di insediarsi in organismi vulnerabili.
Rimani un fuffaro, e di quelli nemmeno troppo intelligenti.

 tessuti di organismi con immunodepressioni.
Ed e' arcinoto che i tumori spesso si comportano come organi 
"immunoprivilegiati".
Ma di rispondere al Vanolicchio ormai mi son rotto.
Un saluto a tutti